Skip to Main Content

Paper Details

Important considerations for trials for peripheral arterial disease: Lessons learned from the paclitaxel mortality signal: A report on behalf of the registry assessment for peripheral interventional Devices (RAPID) Paclitaxel Pathways Program.
Am Heart J
8
2021
Author NameAffiliation
Daniel J BertgesUniversity of Vermont Medical Center
  • 1 - 1

Datasets

Release 1.2